IMA Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.65M | Sell |
2,132
-16
| -0.7% | -$12.2K | 0.16% | 99 |
|
|
2025
Q4 | $1.66M | Sell |
2,148
-23
| -1% | -$15.6K | 0.16% | 100 |
|
|
2025
Q3 | $1.22M | Sell |
2,171
-31
| -1% | -$17.5K | 0.12% | 114 |
|
|
2025
Q2 | $1.16M | Buy |
2,202
+199
| +10% | +$111K | 0.12% | 112 |
|
|
2025
Q1 | $1.27M | Sell |
2,003
-299
| -13% | -$206K | 0.15% | 98 |
|
|
2024
Q4 | $1.64M | Sell |
2,302
-23
| -1% | -$19.3K | 0.2% | 94 |
|
|
2024
Q3 | $2.44M | Sell |
2,325
-392
| -14% | -$436K | 0.53% | 54 |
|
|
2024
Q2 | $2.86M | Sell |
2,717
-60
| -2% | -$58.2K | 1.26% | 25 |
|
|
2024
Q1 | $2.67M | Sell |
2,777
-190
| -6% | -$181K | 1.26% | 26 |
|
|
2023
Q4 | $2.61M | Sell |
2,967
-320
| -10% | -$264K | 1.3% | 27 |
|
|
2023
Q3 | $2.71M | Sell |
3,287
-44
| -1% | -$34.6K | 0.7% | 49 |
|
|
2023
Q2 | $2.39M | Buy |
3,331
+22
| +0.7% | +$17K | 0.61% | 55 |
|
|
2023
Q1 | $2.72M | Sell |
3,309
-205
| -6% | -$155K | 0.7% | 44 |
|
|
2022
Q4 | $2.54M | Sell |
3,514
-120
| -3% | -$88.5K | 0.67% | 46 |
|
|
2022
Q3 | $2.5M | Sell |
3,634
-292
| -7% | -$184K | 0.67% | 45 |
|
|
2022
Q2 | $2.32M | Sell |
3,926
-303
| -7% | -$197K | 0.57% | 57 |
|
|
2022
Q1 | $2.95M | Sell |
4,229
-122
| -3% | -$77.2K | 0.68% | 45 |
|
|
2021
Q4 | $2.75M | Sell |
4,351
-255
| -6% | -$157K | 0.61% | 54 |
|
|
2021
Q3 | $2.79M | Buy |
4,606
+373
| +9% | +$232K | 0.66% | 49 |
|
|
2021
Q2 | $2.36M | Buy |
4,233
+956
| +29% | +$484K | 0.55% | 67 |
|
|
2021
Q1 | $1.55M | Buy |
3,277
+230
| +8% | +$112K | 0.38% | 78 |
|
|
2020
Q4 | $1.47M | Sell |
3,047
-396
| -12% | -$214K | 0.41% | 72 |
|
|
2020
Q3 | $1.93M | Buy |
3,443
+1
| +0% | +$606 | 0.65% | 55 |
|
|
2020
Q2 | $2.15M | Sell |
3,442
-26
| -0.7% | -$14.8K | 0.78% | 46 |
|
|
2020
Q1 | $1.69M | Sell |
3,468
-2,497
| -42% | -$1.03M | 0.75% | 50 |
|
|
2019
Q4 | $2.24M | Sell |
5,965
-399
| -6% | -$134K | 0.83% | 53 |
|
|
2019
Q3 | $1.76M | Sell |
6,364
-1,426
| -18% | -$422K | 0.67% | 61 |
|
|
2019
Q2 | $2.44M | Sell |
7,790
-67
| -0.9% | -$22.3K | 0.91% | 49 |
|
|
2019
Q1 | $3.23M | Buy |
7,857
+1,251
| +19% | +$515K | 1.25% | 26 |
|
|
2018
Q4 | $2.47M | Sell |
6,606
-1,332
| -17% | -$488K | 1.15% | 29 |
|
|
2018
Q3 | $3.21M | Buy |
7,938
+864
| +12% | +$329K | 1.25% | 28 |
|
|
2018
Q2 | $2.44M | Buy |
7,074
+71
| +1% | +$22.2K | 1.02% | 36 |
|
|
2018
Q1 | $2.41M | Sell |
7,003
-24
| -0.3% | -$8.35K | 1.07% | 35 |
|
|
2017
Q4 | $2.64M | Buy |
7,027
+1,724
| +33% | +$698K | 1.18% | 26 |
|
|
2017
Q3 | $2.37M | Sell |
5,303
-532
| -9% | -$253K | 1.1% | 28 |
|
|
2017
Q2 | $2.87M | Sell |
5,835
-621
| -10% | -$272K | 1.38% | 18 |
|
|
2017
Q1 | $2.5M | Sell |
6,456
-757
| -10% | -$281K | 1.26% | 21 |
|
|
2016
Q4 | $2.65M | Sell |
7,213
-560
| -7% | -$213K | 1.63% | 20 |
|
|
2016
Q3 | $3.13M | Buy |
7,773
+276
| +4% | +$111K | 1.79% | 17 |
|
|
2016
Q2 | $2.58M | Sell |
7,497
-1,230
| -14% | -$474K | 1.62% | 23 |
|
|
2016
Q1 | $3.1M | Buy |
8,727
+205
| +2% | +$84.5K | 1.8% | 18 |
|
|
2015
Q4 | $4.48M | Buy |
8,522
+39
| +0.5% | +$21.1K | 2.72% | 4 |
|
|
2015
Q3 | $3.78M | Sell |
8,483
-62
| -0.7% | -$33.3K | 2.4% | 9 |
|
|
2015
Q2 | $4.36M | Sell |
8,545
-75
| -0.9% | -$36.6K | 2.07% | 5 |
|
|
2015
Q1 | $3.89M | Buy |
8,620
+280
| +3% | +$119K | 1.89% | 9 |
|
|
2014
Q4 | $3.42M | Sell |
8,340
-75
| -0.9% | -$29.5K | 1.77% | 12 |
|
|
2014
Q3 | $3.03M | Buy |
8,415
+275
| +3% | +$92.2K | 1.43% | 15 |
|
|
2014
Q2 | $2.3M | Buy |
8,140
+640
| +9% | +$190K | 1.05% | 34 |
|
|
2014
Q1 | $2.25M | Buy |
7,500
+620
| +9% | +$191K | 1.05% | 32 |
|
|
2013
Q4 | $1.89M | Buy |
6,880
+150
| +2% | +$43.1K | 0.9% | 39 |
|
|
2013
Q3 | $2.11M | Buy |
6,730
+4,422
| +192% | +$1.16M | 1.03% | 29 |
|
|
2013
Q2 | $519K | Buy |
+2,308
| New | +$537K | 0.28% | 103 |
|
Other funds holding REGN
VCM
N
IMA Advisory Services's REGN Position: Q1 2026 in Review
IMA Advisory Services reduced its Regeneron Pharmaceuticals (REGN) stake by 0.74% in Q1 2026, selling an estimated $12.2K and leaving 2,132 shares worth $1.65M. The position accounts for 0.16% of the portfolio, ranked #99.
IMA Advisory Services first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.48M in Q4 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- IMA Advisory Services held 2,132 shares of Regeneron Pharmaceuticals worth $1.65M as of Q1 2026.
- IMA Advisory Services sold 16 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $12.2K.
- Regeneron Pharmaceuticals made up 0.16% of IMA Advisory Services's portfolio in Q1 2026, its #99 holding.
- IMA Advisory Services first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- IMA Advisory Services's Regeneron Pharmaceuticals position peaked at $4.48M in Q4 2015.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.